Healthcare Private Equity: The Scrutiny Intensifies

For years, private equity firms operated quietly within the healthcare sector, acquiring hospitals and physician practices with the promise of operational efficiency. However, the narrative has shifted. Lawmakers and federal regulators are now launching aggressive investigations into how this ownership model impacts patient safety, staffing levels, and the rising cost of care. If you have noticed your local hospital changing hands or heard about sudden closures, this legislative push explains why the business of medicine is currently under a federal microscope.

The Catalyst: The Steward Health Care Crisis

The intensity of the current scrutiny is largely driven by the collapse of Steward Health Care. Once the largest physician-owned private for-profit healthcare network in the United States, Steward filed for Chapter 11 bankruptcy in May 2024. This event exposed the dangers of financial engineering in healthcare to the general public and Congress.

Steward was originally acquired by Cerberus Capital Management. Under private equity ownership, the company sold the real estate of its hospitals to a Medical Properties Trust (a REIT) for over $1 billion to pay dividends to investors. This left the hospitals with massive rent payments they eventually could not afford.

The fallout has been severe and concrete:

  • Hospital Closures: Steward was forced to close facilities, including Carney Hospital in Dorchester and Nashoba Valley Medical Center in Ayer, Massachusetts, leaving communities without immediate emergency care.
  • Senate Subpoenas: The Senate Health, Education, Labor, and Pensions (HELP) Committee, led by Senator Bernie Sanders, took the rare step of voting to subpoena Steward CEO Dr. Ralph de la Torre.
  • Criminal Contempt: In September 2024, the Senate unanimously passed a resolution to hold Dr. de la Torre in criminal contempt for refusing to testify, marking the first time in over 50 years the Senate has taken such an action.

Legislative Response: The "Health Over Wealth" Act

Lawmakers are moving beyond hearings and are now drafting legislation specifically targeting the private equity business model in medicine. Senator Ed Markey (D-Mass.) introduced the “Health Over Wealth Act” to put guardrails on these transactions.

This proposed legislation seeks to mandate the following:

  • Transparency: Private equity firms would be required to publicly report debt levels, fees charged to portfolio companies, and staffing data.
  • Escrow Requirements: Firms would have to set aside funds to protect hospitals in the event of bankruptcy, preventing the “strip and run” tactic where investors profit while the hospital fails.
  • REIT Loopholes: The bill targets the tax advantages involved in selling hospital real estate to Real Estate Investment Trusts, a tactic used to extract immediate cash while burdening the hospital with long-term rent.

The FTC and DOJ Antitrust Strategy

While Congress holds hearings, federal agencies are taking legal action. The Federal Trade Commission (FTC), under Chair Lina Khan, and the Department of Justice (DOJ) have launched a cross-government inquiry into private equity’s “roll-up” strategies.

A primary example of this is the FTC’s lawsuit against U.S. Anesthesia Partners (USAP) and its private equity backer, Welsh, Carson, Anderson & Stowe. The FTC alleged that the firm executed a scheme to consolidate anesthesiology practices in Texas to drive up prices.

The government’s argument rests on three main points:

  1. Monopolization: By buying multiple small practices in the same geographic area, PE firms can corner the market and demand higher reimbursement rates from insurance companies.
  2. Price Increases: The FTC cited data suggesting that prices for anesthesia services in Texas rose significantly faster than inflation under USAP’s control.
  3. contractual Leverage: Large consolidated groups can threaten to pull services from hospitals or insurance networks if their price demands are not met.

Impact on Patient Care and Costs

The core of the investigation focuses on whether the profit motive is directly harming patients. Research published in the Journal of the American Medical Association (JAMA) and reviews by the American Antitrust Institute have provided data supporting legislative concerns.

Higher Costs for Patients

When private equity firms acquire physician groups, costs often rise. A common tactic is “surprise billing.” Firms like Envision Healthcare (backed by KKR) and TeamHealth (backed by Blackstone) historically faced scrutiny for acquiring emergency room staffing contracts and moving the doctors out-of-network. While the “No Surprises Act” has curtailed some of this, insurance premiums continue to rise as consolidated providers negotiate higher in-network rates.

Staffing and Quality Concerns

To service the debt placed on these companies during a buyout, operational costs must be cut. This frequently manifests in the following ways:

  • Nurse-to-Patient Ratios: Staffing is often the largest expense for a hospital. Reducing the number of registered nurses (RNs) saves money but is linked to higher rates of patient complications.
  • Replacing Physicians: There is a growing trend of replacing board-certified physicians with nurse practitioners or physician assistants in emergency departments and anesthesia care teams to lower payroll costs.
  • Equipment Shortages: In the Steward Health Care hearings, nurses testified about shortages of basic supplies, including bereavement boxes for deceased newborns, due to unpaid vendor bills.

Sectors Under Watch Beyond Hospitals

The scrutiny is not limited to general hospitals. Private equity has expanded into niche healthcare sectors that are now attracting regulatory attention:

  • Nursing Homes: A study by the National Bureau of Economic Research (NBER) found that going into a PE-owned nursing home increased the probability of death for patients by roughly 10% during the study period, alongside an increase in taxpayer costs.
  • Behavioral Health: Investment firms are rapidly buying autism therapy centers and addiction treatment facilities. The concern here is that firms may prioritize maximizing billable hours over effective, individualized therapy.
  • Hospice Care: Regulators are examining whether profit-driven ownership in hospice care leads to longer average lengths of stay or the enrollment of patients who do not actually qualify for end-of-life care, thereby defrauding Medicare.

Frequently Asked Questions

Why does private equity buy hospitals? Investors are attracted to healthcare because it is viewed as recession-proof. People always need medical care. Furthermore, hospitals often own valuable real estate that can be sold for immediate cash flow.

What is a “roll-up” strategy? This is when a firm buys multiple small providers in a specific region (like dermatology or dentistry clinics) and combines them into one large company. This reduces competition and gives the new company leverage to raise prices.

Has any private equity firm been punished yet? Yes and no. While there have been settlements regarding billing practices, the current push is to hold the private equity parent companies liable, not just the healthcare providers they own. The contempt charges against Steward’s CEO and the FTC lawsuit against Welsh Carson represent a significant escalation in enforcement.

How do I know if my hospital is owned by private equity? It is often difficult to tell because the hospital usually keeps its original name. However, recent transparency laws proposed by the “Health Over Wealth Act” would require facilities to clearly disclose their ownership structure to patients. Currently, you can often find this information by searching the “About Us” section of a hospital’s website or checking financial news regarding the parent health system.